132213-85-5
132213-85-5
Chemical Structure
1-O-Hexadecyl-2-O-docosahexaenoyl-sn-glycero-3-phosphorylcholine
Synonym(s): PC(O-16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
- CAS No.: 132213-85-5
- Formula:C46H82NO7P
- Molecular Weight:792.12
IUPAC Name: (R)-2-(((4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl)oxy)-3-(hexadecyloxy)propyl (2-(trimethylammonio)ethyl) phosphate
InChIKey: QQQQNYAHSSIZBU-HIQXTUQZSA-N
SMILES: CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O[C@H](COCCCCCCCCCCCCCCCC)COP(=O)([O-])OCC[N+](C)(C)C
Biological Activity: 1-O-Hexadecyl-2-O-docosahexaenoyl-sn-glycero-3-phosphorylcholine is an endogenous metabolite present in Urine that can be used for the research of Obesity[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
1-O-Hexadecyl-2-O-docosahexaenoyl-sn-glycero-3-phosphorylcholine | 99.6% | 1-O-Hexadecyl-2-O-docosahexaenoyl-sn-glycero-3-phosphorylcholine is an endogenous metabolite present in Urine that can be used for the research of Obesity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Lee N, et al. Endogenous toxic metabolites and implications in cancer therapy. Oncogene. 2020 Aug;39(35):5709-5720. [Content Brief]
- [2]. Cho K, et al. Combined untargeted and targeted metabolomic profiling reveals urinary biomarkers for discriminating obese from normal-weight adolescents. Pediatr Obes. 2017 Apr;12(2):93-101. [Content Brief]
